[PHARMA] QoQ TTM Result on 30-Sep-2014 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-Nov-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
30-Sep-2014 [#3]
Profit Trend
QoQ- 16.78%
YoY- 194.71%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Revenue 2,113,938 2,126,165 2,122,933 2,063,690 2,002,411 1,914,972 1,946,639 5.66%
PBT 126,467 126,033 125,580 120,733 109,249 94,232 92,997 22.81%
Tax -26,277 -26,528 -31,355 -41,862 -41,209 -35,978 -36,236 -19.33%
NP 100,190 99,505 94,225 78,871 68,040 58,254 56,761 46.20%
-
NP to SH 99,663 99,421 93,844 77,960 66,756 56,646 55,200 48.43%
-
Tax Rate 20.78% 21.05% 24.97% 34.67% 37.72% 38.18% 38.96% -
Total Cost 2,013,748 2,026,660 2,028,708 1,984,819 1,934,371 1,856,718 1,889,878 4.33%
-
Net Worth 528,477 528,173 525,351 507,124 502,293 515,022 486,672 5.66%
Dividend
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Div 88,011 80,234 72,463 57,457 44,519 42,973 41,446 65.43%
Div Payout % 88.31% 80.70% 77.22% 73.70% 66.69% 75.86% 75.08% -
Equity
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Net Worth 528,477 528,173 525,351 507,124 502,293 515,022 486,672 5.66%
NOSH 259,057 258,908 258,794 258,737 258,914 258,805 258,868 0.04%
Ratio Analysis
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
NP Margin 4.74% 4.68% 4.44% 3.82% 3.40% 3.04% 2.92% -
ROE 18.86% 18.82% 17.86% 15.37% 13.29% 11.00% 11.34% -
Per Share
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
RPS 816.01 821.20 820.32 797.60 773.39 739.93 751.98 5.61%
EPS 38.47 38.40 36.26 30.13 25.78 21.89 21.32 48.37%
DPS 34.00 31.00 28.00 22.20 17.20 16.61 16.01 65.44%
NAPS 2.04 2.04 2.03 1.96 1.94 1.99 1.88 5.61%
Adjusted Per Share Value based on latest NOSH - 258,737
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
RPS 146.68 147.52 147.30 143.19 138.94 132.87 135.07 5.66%
EPS 6.92 6.90 6.51 5.41 4.63 3.93 3.83 48.50%
DPS 6.11 5.57 5.03 3.99 3.09 2.98 2.88 65.33%
NAPS 0.3667 0.3665 0.3645 0.3519 0.3485 0.3573 0.3377 5.66%
Price Multiplier on Financial Quarter End Date
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Date 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 -
Price 7.13 6.00 4.58 4.63 4.61 4.46 4.45 -
P/RPS 0.87 0.73 0.56 0.58 0.60 0.60 0.59 29.64%
P/EPS 18.53 15.62 12.63 15.37 17.88 20.38 20.87 -7.64%
EY 5.40 6.40 7.92 6.51 5.59 4.91 4.79 8.34%
DY 4.77 5.17 6.11 4.79 3.73 3.72 3.60 20.69%
P/NAPS 3.50 2.94 2.26 2.36 2.38 2.24 2.37 29.77%
Price Multiplier on Announcement Date
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Date 17/08/15 18/05/15 23/02/15 21/11/14 21/08/14 14/05/14 24/02/14 -
Price 5.65 6.91 5.28 4.45 4.62 4.70 4.29 -
P/RPS 0.69 0.84 0.64 0.56 0.60 0.64 0.57 13.62%
P/EPS 14.69 17.99 14.56 14.77 17.92 21.47 20.12 -18.96%
EY 6.81 5.56 6.87 6.77 5.58 4.66 4.97 23.43%
DY 6.02 4.49 5.30 4.99 3.72 3.53 3.73 37.71%
P/NAPS 2.77 3.39 2.60 2.27 2.38 2.36 2.28 13.89%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment